These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 20166889)

  • 1. The applied biochemistry of PEDF and implications for tissue homeostasis.
    Broadhead ML; Becerra SP; Choong PF; Dass CR
    Growth Factors; 2010 Aug; 28(4):280-5. PubMed ID: 20166889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-function relationships of PEDF.
    Kawaguchi T; Yamagishi SI; Sata M
    Curr Mol Med; 2010 Apr; 10(3):302-11. PubMed ID: 20236052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell and molecular biology underpinning the effects of PEDF on cancers in general and osteosarcoma in particular.
    Chandolu V; Dass CR
    J Biomed Biotechnol; 2012; 2012():740295. PubMed ID: 22690122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pigment epithelium-derived factor: a multimodal tumor inhibitor.
    Ek ET; Dass CR; Choong PF
    Mol Cancer Ther; 2006 Jul; 5(7):1641-6. PubMed ID: 16891449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Evidence and Potential Mechanisms of Therapeutic Action of PEDF in Cervical Cancer Treatment.
    Han J; Guo J
    Curr Mol Med; 2015; 15(5):446-55. PubMed ID: 26122658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of PEDF in tumor growth and metastasis.
    Hoshina D; Abe R; Yamagishi SI; Shimizu H
    Curr Mol Med; 2010 Apr; 10(3):292-5. PubMed ID: 20236054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of PEDF: a multi-functional serpin family protein.
    Filleur S; Nelius T; de Riese W; Kennedy RC
    J Cell Biochem; 2009 Apr; 106(5):769-75. PubMed ID: 19180572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth suppression of cervical carcinoma by pigment epithelium-derived factor via anti-angiogenesis.
    Yang J; Chen S; Huang X; Han J; Wang Q; Shi D; Cheng R; Gao G; Yang X
    Cancer Biol Ther; 2010 Jun; 9(12):967-74. PubMed ID: 20364117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of pigment epithelium-derived factor with radiotherapy enhances the antitumor effects on nasopharyngeal carcinoma by downregulating vascular endothelial growth factor expression and angiogenesis.
    Xu Z; Fang S; Zuo Y; Zhang Y; Cheng R; Wang Q; Yang Z; Cai W; Ma J; Yang X; Gao G
    Cancer Sci; 2011 Oct; 102(10):1789-98. PubMed ID: 21707863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEDF as a treatment for cervical cancer.
    Murray AR; Ma JX
    Cancer Biol Ther; 2010 Jun; 9(12):975-7. PubMed ID: 20424516
    [No Abstract]   [Full Text] [Related]  

  • 11. Topical application of anti-angiogenic peptides based on pigment epithelium-derived factor can improve psoriasis.
    Abe R; Yamagishi S; Fujita Y; Hoshina D; Sasaki M; Nakamura K; Matsui T; Shimizu T; Bucala R; Shimizu H
    J Dermatol Sci; 2010 Mar; 57(3):183-91. PubMed ID: 20060688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pigment epithelium-derived factor reduces apoptosis and pro-inflammatory cytokine gene expression in a murine model of focal retinal degeneration.
    Wang Y; Subramanian P; Shen D; Tuo J; Becerra SP; Chan CC
    ASN Neuro; 2013 Nov; 5(5):e00126. PubMed ID: 24160756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining a mechanistic link between pigment epithelium-derived factor, docosahexaenoic acid, and corneal nerve regeneration.
    Pham TL; He J; Kakazu AH; Jun B; Bazan NG; Bazan HEP
    J Biol Chem; 2017 Nov; 292(45):18486-18499. PubMed ID: 28972155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PEDF: a potential molecular therapeutic target with multiple anti-cancer activities.
    Ek ET; Dass CR; Choong PF
    Trends Mol Med; 2006 Oct; 12(10):497-502. PubMed ID: 16962374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pigment epithelium-derived factor as an anticancer drug and new treatment methods following the discovery of its receptors: a patent perspective.
    Manalo KB; Choong PF; Becerra SP; Dass CR
    Expert Opin Ther Pat; 2011 Feb; 21(2):121-30. PubMed ID: 21204726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo biological activity of PEDF against a range of tumors.
    Broadhead ML; Dass CR; Choong PF
    Expert Opin Ther Targets; 2009 Dec; 13(12):1429-38. PubMed ID: 19922300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pigment Epithelium-Derived Factor (PEDF) as a Regulator of Wound Angiogenesis.
    Michalczyk ER; Chen L; Fine D; Zhao Y; Mascarinas E; Grippo PJ; DiPietro LA
    Sci Rep; 2018 Jul; 8(1):11142. PubMed ID: 30042381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathophysiological role of PEDF in bone diseases.
    Broadhead ML; Akiyama T; Choong PF; Dass CR
    Curr Mol Med; 2010 Apr; 10(3):296-301. PubMed ID: 20236053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of pigment epithelium-derived factor (PEDF) reduces proteinuria by suppressing decreased nephrin and increased VEGF expression in the glomeruli of adriamycin-injected rats.
    Fujimura T; Yamagishi S; Ueda S; Fukami K; Shibata R; Matsumoto Y; Kaida Y; Hayashida A; Koike K; Matsui T; Nakamura K; Okuda S
    Nephrol Dial Transplant; 2009 May; 24(5):1397-406. PubMed ID: 19042927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-tumor effects of pigment epithelium-derived factor (PEDF): implication for cancer therapy. A mini-review.
    Belkacemi L; Zhang SX
    J Exp Clin Cancer Res; 2016 Jan; 35():4. PubMed ID: 26746675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.